Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04069013 · ClinicalTrials.gov registry record · NA
Standard vs Mini-PCNL for the Treatment of Stone Disease
A NA study of Kidney Diseases and Kidney Stone, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT04069013: Completed NA study of Kidney Diseases and Kidney Stone, sponsored by The Cleveland Clinic.
NCT04069013 is a NA study of Kidney Diseases and Kidney Stone that has completed, run by The Cleveland Clinic. The registered enrollment target is 18 participants, below the 1,785-participant average among 38 other Kidney Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04069013, a NA study of Kidney Diseases and Kidney Stone, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized comparison of patient outcomes following standard PCNL versus mini-PCNL.
Primary Outcome
Blood loss as estimated by postoperative decreases in hemoglobin Blood loss as estimated by postoperative decreases in hemoglobin Blood loss as estimated by postoperative decreases in hemoglobin Blood loss as estimated by postoperative decreases in hemoglobin Post-op decreases in hemoglobin
Conditions Studied
Interventions
- PROCEDURE PCNL
Study Locations (1)
Ohio
- Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2022-05-01 |
| Est. Completion | 2025-11-11 |
| Phase | NA |
What the finished NCT04069013 record still lists
NCT04069013 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,785-participant average among 38 other Kidney Diseases trials with a reported enrollment target (99% lower).
The record links to 5 conditions, with Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which PCNL is the first listed.
NCT04069013 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04069013 about?
NCT04069013 is a clinical study titled "Standard vs Mini-PCNL for the Treatment of Stone Disease". Randomized comparison of patient outcomes following standard PCNL versus mini-PCNL.
What is the current status of trial NCT04069013?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2022-05-01. Estimated completion is 2025-11-11.
What conditions does trial NCT04069013 study?
This clinical trial studies the following conditions: Kidney Diseases, Kidney Stone, Urolithiasis, Kidney Calculi, Ureteral Calculi.
What interventions are being tested in trial NCT04069013?
The interventions under investigation include: PCNL (PROCEDURE).
Who is sponsoring clinical trial NCT04069013?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04069013 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04069013's enrollment target sits among peer trials
18 38th of 38 higher than 1 of 38 other Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
RECRUITING · NA
-
Supporting VETerans With Kidney Disease Through Food As Medicine
RECRUITING · NA
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Dietary Intervention to Improve Kidney Transplant Outcomes
RECRUITING · NA
-
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
RECRUITING · NA
-
Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI